All of the BMV vaccines mentioned above induce strong IFN‐γ production, which, while strongly associated with cancer immunity, also upregulates immunosuppressive factors in the tumor microenvironment, especially programmed death 1 ligand 1(PD‐L1). Here, IFNG is linked to neoplasm.